| Literature DB >> 35310403 |
Cameron J Gettel1,2, Bradford Tinloy3, Susan M Nedza4, Michael A Granovsky5, Pawan Goyal6, Aisha T Terry7, Arjun K Venkatesh1,8.
Abstract
The Centers for Medicare & Medicaid Services (CMS) implemented the Merit-based Incentive Payment System (MIPS) to accelerate the transition of physician payment toward value-based care models and away from traditional fee-for-service payment programs. In recent years, CMS has sought to modify the program by developing a MIPS Value Pathway (MVP) framework intended to use existing and future physician quality and cost measures to reward value-based care delivery. This article describes the multi-step process of the MVP Task Force, convened by the American College of Emergency Physicians (ACEP) to develop an emergency medicine-specific MVP proposal informed by diverse stakeholder perceptions regarding: (1) which existing quality measures reflect high quality emergency care, and (2) the degree to which emergency clinicians can impact clinical outcomes and cost for the care domains captured by existing quality measures. The MVP Task Force synthesized stakeholder feedback and underwent a consensus-building approach to develop the "Adopting Best Practices and Promoting Patient Safety within Emergency Medicine" MVP, recently reviewed and approved by CMS for national implementation starting in 2023. Our process and findings have broad implications for clinicians, administrators, and policymakers navigating the continued transition to value-based care in conjunction with CMS's implementation of the MVP framework.Entities:
Keywords: MIPS Value Pathway; consensus building; emergency medicine; quality measurement; value‐based care
Year: 2022 PMID: 35310403 PMCID: PMC8918116 DOI: 10.1002/emp2.12672
Source DB: PubMed Journal: J Am Coll Emerg Physicians Open ISSN: 2688-1152
MVP Guiding Principles
| MVP guiding principles |
|---|
| 1. MVPs should consist of limited, connected complementary sets of measures and activities that are meaningful to clinicians, which will reduce clinician burden, align scoring, and lead to sufficient comparative data. |
| 2. MVPs should include measures and activities that would result in providing comparative performance data that is valuable to patients and caregivers in evaluating clinician performance and making choices about their care; MVPs will enhance this comparative performance data as they allow subgroup reporting that comprehensively reflects the services provided by multispecialty groups. |
| 3. MVPs should include measures selected using the “Meaningful Measures” approach and wherever possible, the patient voice must be included, to encourage performance improvements in high priority areas. |
| 4. MVPs should reduce barriers to APM participation by including measures that are part of APMs where feasible, and by linking cost and quality measurement. |
| 5. MVPs should support the transition to digital quality measures. |
Abbreviations: APM, alternative payment model; MVP, MIPS Value Pathway.
Emergency physician agreement with inclusion of existing emergency care quality measures in an emergency medicine‐specific MVP
| Measure ID—label | Disagree | Agree | Mean |
|---|---|---|---|
| QPP Measures | |||
| 254—Ultrasound determination of pregnancy location for pregnant patients with abdominal pain | 10 | 108 | 5.07 |
| 415—ED utilization of CT for minor blunt head trauma for patients aged ≥18 years old | 20 | 97 | 4.81 |
| 416—ED utilization of CT for minor blunt head trauma for patients 2 through 17 years old | 22 | 95 | 4.81 |
| 116—Avoidance of antibiotic treatment in adults with acute bronchitis | 22 | 95 | 4.68 |
| 333—Computerized tomography for acute sinusitis | 30 | 87 | 4.50 |
| 331—Antibiotic prescribed for acute viral sinusitis | 25 | 93 | 4.48 |
| 93—Acute otitis externa: systemic antimicrobial therapy | 28 | 89 | 4.37 |
| 107—Adult major depressive disorder: suicide risk assessment | 32 | 86 | 4.28 |
| 66—Appropriate testing for children with pharyngitis | 26 | 91 | 4.22 |
| 332—Appropriate choice of antibiotic: amoxicillin with or without clavulanate prescribed for patients with acute bacterial sinusitis | 30 | 88 | 4.14 |
| 187—Stroke and stroke rehabilitation: thrombolytic therapy | 42 | 76 | 3.93 |
| 317—Screening for high blood pressure and follow‐up documented | 73 | 45 | 3.00 |
| QCDR Measures | |||
| ECPR 55—Avoidance of long‐acting or extended‐release opiate prescriptions and opiate prescriptions for >3 days duration for acute pain | 14 | 104 | 5.08 |
| ECPR 41—Rh status evaluation and treatment of pregnant women at risk of fetal blood exposure | 13 | 105 | 5.05 |
| ECPR 46—Avoidance of opiates for low back pain or migraines | 16 | 102 | 4.94 |
| ACEP 52—Appropriate ED utilization of lumbar spine imaging for atraumatic low back pain | 11 | 107 | 4.85 |
| ECPR 39—Avoid head CT for patients with uncomplicated syncope | 18 | 99 | 4.85 |
| ACEP 55—ED utilization of CT for minor blunt head trauma for patients 2 through 17 years old | 15 | 102 | 4.83 |
| ACEP 22—Appropriate ED utilization of CT for pulmonary embolism | 21 | 96 | 4.79 |
| ACEP 57—Avoidance of opioid therapy for migraine, low back pain, dental pain | 22 | 96 | 4.70 |
| ACEP 58—Appropriate treatment for adults with upper respiratory infection | 17 | 101 | 4.69 |
| ACEP 54—Utilization of FAST exam in the ED | 20 | 98 | 4.51 |
| ECPR 51—Discharge prescription of naloxone after opioid poisoning or overdose | 29 | 88 | 4.50 |
| ACEP 31—Appropriate Foley catheter use in the ED | 27 | 91 | 4.44 |
| ACEP 53—Appropriate use of imaging for recurrent renal colic | 26 | 91 | 4.42 |
| ACEP 21—Coagulation studies in patients presenting with chest pain with no coagulopathy or bleeding | 37 | 80 | 4.28 |
| ECPR 52—Appropriate treatment of psychosis and agitation in the ED | 34 | 84 | 4.25 |
| ACEP 48—Septic shock: lactate level measurement, antibiotics ordered, and fluid resuscitation | 30 | 88 | 4.17 |
| ECPR 40—Initiation of the initial sepsis bundle | 32 | 85 | 4.03 |
| ACEP 56—Follow‐up care coordination documented in discharge summary | 42 | 76 | 3.94 |
| ACEP 30—Septic shock: lactate clearance rate ≥10% | 51 | 67 | 3.59 |
| ACEP 25—Tobacco use: screening and cessation intervention for patients with asthma and COPD | 64 | 54 | 3.34 |
| ACEP 50—ED median time from ED arrival to ED departure for discharged ED patients for adult patients | 66 | 52 | 3.18 |
| ACEP 51—ED median time from ED arrival to ED departure for discharged ED patients for pediatric patients | 66 | 52 | 3.16 |
| ECPR 50—Door to diagnostic evaluation by a clinicians within 30 min: urgent care patients | 76 | 42 | 2.86 |
| ECPR 53—Clinician reporting of loss of consciousness to state Department of Public Health or Department of Motor Vehicles | 88 | 30 | 2.51 |
Abbreviations: ACEP, American College of Emergency Physicians; COPD, chronic obstructive pulmonary disease; CT, computed tomography; ECPR, Emergency Clinical Performance Registry; FAST, focused assessment with sonography for trauma; QCDR, qualified clinical data registry; QPP, Quality Payment Program.
Captures responses of “Somewhat–Strongly” agree with inclusion of the measure within an emergency medicine‐specific MVP.
Denotes weighted mean.
FIGURE 1Perceived emergency clinician impact on clinical outcome and cost of 14 clinical care domains. Clinical care domains are placed in 1 cell within the 3 × 3 impact matrix based on a plurality of physician stakeholder responses
FIGURE 2Perceived emergency clinician impact on clinical outcome and cost of 14 clinical care domains. Green represents a perceived high impact; yellow represents a perceived moderate impact; red represents a perceived low impact
Conditions addressed and measure IDs of 5 MVPs considered by the MVP Task Force
| Proposed MVP | Complaints/conditions addressed | Measure IDs |
|---|---|---|
| Time‐critical high‐acuity conditions | Stroke, myocardial infarction, sepsis | QPP 187, ACEP 30, ACEP 48, ECPR 40 |
| Acute undifferentiated cardiopulmonary illnesses | Chest pain, pulmonary embolism | ACEP 21, ACEP 22 |
| Undifferentiated high‐risk complaints | Chest pain, abdominal pain, headache, back pain | QPP 116, QPP 254, QPP 321, QPP 331, ACEP 21, ACEP 50, ACEP 52, ECPR 46, ECPR 55 |
| Low‐acuity infectious conditions | Pharyngitis, sinusitis, bronchitis | QPP 66, QPP 93, QPP 116, QPP 331, QPP 332, QPP 333, ACEP 58 |
| Trauma | Blunt head trauma, FAST | QPP 415, QPP 416, ACEP 54, ACEP 55 |
Abbreviations: ACEP, American College of Emergency Physicians; ECPR, Emergency Clinical Performance Registry; FAST, focused assessment with sonography for trauma; MVP, MIPS Value Pathways; QPP, Quality Payment Program.
Characteristics of quality measures within the “undifferentiated high‐risk complaints” MVP
| Measure ID/title | Measure type | Collection type | “Topped Out” status | Attribution concerns | Frequently used measure |
|---|---|---|---|---|---|
| QPP 116—Avoidance of antibiotic treatment in adults with acute bronchitis | Process | QPP | No | No | Yes |
| QPP254—Ultrasound determination of pregnancy location for pregnant patients with abdominal pain | Process | QPP | Yes | No | Yes |
| QPP321—CAPHS for MIPS clinician/group survey | PRO‐PM | CAHPS | No | No | No |
| QPP331—Adult sinusitis: Antibiotic prescribed for acute viral sinusitis (overuse) | Process | QPP | No | No | Yes |
| ACEP21—Coagulation studies in patients presenting with chest pain with no coagulopathy or bleeding | Process | QCDR | No | No | Yes |
| ACEP50—ED median time from ED arrival to ED departure for all adult patients | Outcome | QCDR | No | Yes; Impact of institutional boarding | Yes |
| ACEP52—Appropriate ED utilization of lumbar spine imaging for atraumatic low back pain | Process | QCDR | No | No | No |
| ECPR46—Avoidance of opiates for low back pain or migraines | Process | QCDR | No | No | No |
| ECPR55—Avoidance of long‐acting or extended‐release opiate prescriptions and opiate prescriptions for greater than 3 days duration for acute pain | Process | QCDR | No | No | No |
Abbreviations: ACEP, American College of Emergency Physicians; CAHPS, Consumer Assessment of Healthcare Providers and Systems; ECPR, Emergency Clinical Performance Registry; MVP, MIPS Value Pathways; PRO‐PM, patient‐reported outcome‐based performance measure; QCDR; QPP, Quality Payment Program; QCDR, Qualified Clinical Data Registry.
Identifies quality measures in which performance is high and unvarying that meaningful distinctions and improvement in performance is difficult. .
Conceptually noted to be a potential overlap with or dependence on additional specialties aside from emergency medicine, potentially limiting the perceived impact an emergency clinician could be expected to have on the clinical outcome.
Noted if the quality measure was a top 10 frequently measure mapped by ACEP CEDR based on the number of reporting tax identification numbers. .
Quality measures within the CMS final rule‐approved emergency medicine MVP
| The “Adopting Best Practices and Promoting Patient Safety within Emergency Medicine” MVP | |
|---|---|
| Intent: Improve patient outcomes and promote the transition to value‐based care by allowing clinicians to focus on a set of emergency medicine‐specific clinical conditions previously identified to have wide variation in healthcare utilization and cost outcomes |
Note: Within the MVP framework, clinicians will need to report quality measures in 4 performance categories: Quality, Improvement Activities, Cost, and Promoting Interoperability. Included measures within the Quality and Improvement Activities are shown above, with clinicians anticipated to be required to submit only a subset of these measures, with the exact amount yet to be determined by the CMS.
Abbreviations: ACEP, American College of Emergency Physicians; BE, beneficiary engagement; CAHPS, Consumer Assessment of Healthcare Providers and Systems; CC, care coordination; ECPR, Emergency Clinical Performance Registry; IA, improvement activity; MVP, MIPS Value Pathways; PSPA, Patient Safety and Practice Assessment; QPP, Quality Payment Program; QCDR; Qualified Clinical Data Registry.